Retatrutide Research and the Laboratory Infrastructure Behind Triple-Agonist Peptides
More than 80 peptide drugs have reached the market since insulin was introduced almost a century ago, a figure documented by Muttenthaler and colleagues in their 2021 survey of peptide drug discovery for Nature Reviews Drug Discovery. Set against the small-molecule catalogue that number looks modest, but it badly understates what sits behind it: a…
